Arnaud de Lassence
Overview
Explore the profile of Arnaud de Lassence including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zahar J, Nguile-Makao M, Francais A, Schwebel C, Garrouste-Orgeas M, Goldgran-Toledano D, et al.
Crit Care Med
. 2009 Jul;
37(9):2545-51.
PMID: 19623046
Objectives: : To build and validate a ventilator-associated pneumonia risk score for benchmarking. The rate of ventilator-associated pneumonia varies widely with case-mix, a fact that has limited its use for...
2.
Azoulay E, Mokart D, Rabbat A, Pene F, Kouatchet A, Bruneel F, et al.
Crit Care Med
. 2007 Dec;
36(1):100-7.
PMID: 18090351
Objective: To describe the diagnostic yields of test strategies with and without fiberoptic bronchoscopy and bronchoalveolar lavage (FO-BAL), as well as outcomes, in cancer patients with acute respiratory failure (ARF)....
3.
Moreau D, Timsit J, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar J, et al.
Chest
. 2007 May;
131(6):1735-41.
PMID: 17475637
Background: Thrombocytopenia is common in ICU patients. The objective of this study was to evaluate possible links between declining platelet counts early in the ICU stay and survival. Methods: All...
4.
Clech C, Alberti C, Vincent F, Garrouste-Orgeas M, de Lassence A, Toledano D, et al.
Crit Care Med
. 2006 Nov;
35(1):132-8.
PMID: 17133180
Objective: To examine the association between the performance of a tracheostomy and intensive care unit and postintensive care unit mortality, controlling for treatment selection bias and confounding variables. Design: Prospective,...
5.
Garrouste-Orgeas M, Timsit J, Tafflet M, Misset B, Zahar J, Soufir L, et al.
Clin Infect Dis
. 2006 Apr;
42(8):1118-26.
PMID: 16575729
Background: Overall rates of bloodstream infection (BSI) are often used as quality indicators in intensive care units (ICUs). We investigated whether ICU-acquired BSI increased mortality (by > or = 10%)...
6.
Eveillard M, de Lassence A, Lancien E, Barnaud G, Ricard J, Joly-Guillou M
Infect Control Hosp Epidemiol
. 2006 Feb;
27(2):181-4.
PMID: 16465635
We compared the sensitivity of screening with nasal culture alone with that of a multiple-site screening method for the identification of carriers of methicillin-resistant Staphylococcus aureus at hospital admission. If...
7.
Azoulay E, Timsit J, Tafflet M, de Lassence A, Darmon M, Zahar J, et al.
Chest
. 2006 Jan;
129(1):110-7.
PMID: 16424420
Background: Recovery of Candida from the respiratory tract of a critically ill patient receiving mechanical ventilation (MV) usually indicates colonization rather than infection of the respiratory tract. However, interactions between...
8.
de Lassence A, Timsit J, Tafflet M, Azoulay E, Jamali S, Vincent F, et al.
Anesthesiology
. 2006 Jan;
104(1):5-13.
PMID: 16394682
Background: The risk factors and outcomes of critically ill patients with iatrogenic pneumothorax (IP) have not been studied in a large unselected intensive care unit (ICU) population. Methods: The authors...
9.
de Lassence A, Hidri N, Timsit J, Joly-Guillou M, Thiery G, Boyer A, et al.
Clin Infect Dis
. 2005 Dec;
42(2):170-8.
PMID: 16355325
Background: Glycopeptide-intermediate Staphylococcus aureus (GISA) is emerging as a cause of nosocomial infection and outbreaks of infection and colonization in intensive care units (ICUs). We describe an outbreak of GISA...
10.
Zahar J, Clech C, Tafflet M, Garrouste-Orgeas M, Jamali S, Mourvillier B, et al.
Clin Infect Dis
. 2005 Oct;
41(9):1224-31.
PMID: 16206094
Background: Excess mortality associated with methicillin resistance in patients with Staphylococcus aureus ventilator-associated pneumonia (SA-VAP), taking into account such confounders as treatment adequacy and time in the intensive care unit...